WuXi Biologics (Cayman) Inc. (BKK:WUXI06)

Thailand flag Thailand · Delayed Price · Currency is THB
3.380
+0.200 (6.29%)
At close: Dec 4, 2025
Market Cap 552.54B
Revenue (ttm) 90.92B
Net Income (ttm) 19.02B
Shares Out n/a
EPS (ttm) 4.48
PE Ratio 29.04
Forward PE 23.07
Dividend n/a
Ex-Dividend Date n/a
Volume 31,096
Average Volume 128,424
Open 3.220
Previous Close 3.180
Day's Range 3.220 - 3.380
52-Week Range 3.160 - 4.020
Beta n/a
RSI 46.95
Earnings Date Nov 19, 2025

About WuXi Biologics

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufact... [Read more]

Industry Commercial Physical and Biological Research
Founded 2014
Employees 12,575
Stock Exchange Stock Exchange of Thailand
Ticker Symbol WUXI06
Full Company Profile

Financial Performance

In 2024, WuXi Biologics's revenue was 18.68 billion, an increase of 9.63% compared to the previous year's 17.03 billion. Earnings were 3.36 billion, a decrease of -1.28%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.